Rapid UPLC-MS/MS method for the determination of sufentanil in human plasma and its application in target-controlled infusion system

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 4, 2011, Pages 838-844

  Liang, Lili ^a   Wan, Shanhe ^a   Xiao, Jinfang ^a   Zhang, Jiajie ^a   Gu, Miaoning ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Human plasma; Pharmacokinetic; Sufentanil; Target controlled infusion (TCI); UPLC ESI MS MS

Indexed keywords

ACETONITRILE; FENTANYL; SUFENTANIL; WATER;

ACCURACY; ADULT; ARTICLE; CALIBRATION; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; ELUTION; FLOW RATE; HUMAN; INFUSION SYSTEM; POSITIVE ION ELECTROSPRAY; PREDICTION; PRIORITY JOURNAL; STANDARD; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

ABDOMEN; ADULT; ANALGESICS, OPIOID; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; DRUG THERAPY, COMPUTER-ASSISTED; HUMANS; INFUSION PUMPS; MICROCHEMISTRY; MIDDLE AGED; MODELS, BIOLOGICAL; PERIOPERATIVE PERIOD; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUFENTANIL; TANDEM MASS SPECTROMETRY; TECHNOLOGY, PHARMACEUTICAL; YOUNG ADULT;

EID: 78650238342     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.11.016     Document Type: Article

References (26)

1. Pandin P.C., Cantraine F., Ewalenko P., Deneu S.C., Coussaert E., d'Hollander A.A. Predictive accuracy of target-controlled propofol and sufentanil coinfusion in long-lasting surgery. Anesthesiology 2000, 93:653-661.
2. Zhao Y., Duan J., Wu X., Jiang J., Lu W., et al. Two-stage analysis of pharmacokinetics of sufentanil administered by target-controlled infusion in Chinese patients. Chin. Med. J. 2009, 122:1979-1984.
3. Martorano P., Facco E., Falzetti G., Pelaia P. Spectral entropy assessment with auditory evoked potential in neuroanesthesia. Clin. Neurophysiol. 2007, 118:505-512.
4. Derrode N., Lebrun F., Levron J.C., Chauvin M., Debaene B. Influence of peroperative opioid on postoperative pain after major abdominal surgery: sufentanil TCI versus remifentanil TCI. A randomized, controlled study. Br. J. Anaesth. 2003, 91:842-849.
5. Jäppinen A., Turpeinen M., Kokki H., Rasi A., Ojanen T., Pelkonen O., Naaranlahti T. Stability of sufentanil and levobupivacaine solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringes. Eur. J. Pharm. Sci. 2003, 19:31-36.
6. Lambropoulos J., Spanos G.A., Lazaridis N.V. Development and validation of an HPLC assay for fentanyl, alfentanil, and sufentanil in swab samples. J. Pharm. Biomed. Anal. 2000, 15:421-428.
7. Movig K.L., Langen M.C., Egberts A.C. Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 1999, 21:845-850.
8. Gergov M., Nokua P., Vuori E., Ojanperä I. Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry. Forensic Sci. Int. 2009, 186:36-43.
9. Schmidt R., Bremerich D.H., Geisslinger G. High sensitive determination of sufentanil in human plasma of parturients and neonates following patient-controlled epidural analgesia (PCEA). J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2006, 836:98-107.
10. Palleschi L., Lucentini L., Ferretti E., Anastasi F., Amoroso M., Draisci G. Quantitative determination of sufentanil in human plasma by liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2003, 32:329-336.
11. Van Nimmen N.F., Poels K.L., Veulemans H.A. Highly sensitive gas chromatographic-mass spectrometric screening method for the determination of picogram levels of fentanyl, sufentanil and alfentanil and their major metabolites in urine of opioid exposed workers. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2004, 804:375-387.
12. Kintz P., Villain M., Dumestre V., Cirimele V. Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Sci. Int. 2005, 153:81-84.
13. Woestenborghs R.J., Timmerman P.M., Cornelissen M.L., Van Rompaey F.A., Gepts E., Camu F., Heykants J.J., Stanski DR D.R. Assay methods for sufentanil in plasma. Radioimmunoassay versus gas chromatography-mass spectrometry. Anesthesiology 1994, 80:666-670.
14. Fryirs B., Woodhouse A., Huang J.L., Dawson M., Mather L.E. Determination of subnanogram concentrations of fentanyl in plasma by gas chromatography-mass spectrometry: comparison with standard radioimmunoassay. J. Chromatogr. B: Biomed. Sci. Appl. 1997, 688:79-85.
15. Martens-Lobenhoffer J. Very sensitive and specific determination of sufentanil in human serum applying liquid chromatography-two stage mass spectrometry. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2002, 769:227-233.
16. Guidance for Industry, Bioanalytical Method Validation May 2001, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM).
17. Gepts E., Shafer S.L., Camu F., Stanski D.R., Woestenborghs R., Van Peer A., Heykants J.J. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995, 83:1194-1204.
18. Dodde W.I., Maring J.G., Hendriks G., Wachters F.M., Groen H.J., de Vries E.G., Uges D.R. Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC. Ther. Drug Monit. 2003, 25:433-440.
19. Churchwell M.I., Twaddle N.C., Meeker L.R., Doerge DR D.R. Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 825:134-143.
20. Pedraglio S., Rozio M.G., Misiano P., Reali V., Dondio G., Bigogno C. New perspectives in bio-analytical techniques for preclinical characterization of a drug candidate: UPLC-MS/MS in in vitro metabolism and pharmacokinetic studies. J. Pharm. Biomed. Anal. 2007, 44:665-673.
21. Varvel J.R., Donoho D.L., Shafer S.L. Measuring the predictive performance of computer-controlled infusion pumps. J. Pharmacokinet. Biopharm. 1992, 20:63-94.
22. Slepchenko G., Simon N., Goubaux B., Levron J.C., Le Moing J.P., Raucoules-Aimé M. Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology 2003, 98:65-73.
23. Zhao Y., Zhang L.P., Wu X.M., Jiang J.Y., Duan J.L., et al. Clinical evaluation of target controlled infusion system for sufentanil administration. Chin. Med. J. 2009, 122:2503-2508.
24. Hudson R.J., Henderson B.T., Thomson I.R., Moon M., Peterson M.D. Pharmacokinetics of sufentanil in patients undergoing coronary artery bypass graft surgery. J. Cardiothorac. Vasc. Anesth. 2001, 15:693-699.
25. Coetzee J.F., Glen J.B., Wium C.A., Boshoff L. Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets. Anesthesiology 1995, 82:1328-1345.
26. Wang X., Zheng H., Zhu Z., Wei Y., Chen I. Clinical pharmacokinetics of paclitaxel liposome with a new route of administration in human based on the analysis with ultra performance liquid chromatography. J. Pharm. Sci. 2010, 99:4746-4752.